Cambridge Investment Research Advisors’s Innovator US Equity Accelerated 9 Buffer ETF April XBAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,286
Closed -$204K 4089
2025
Q4
$204K Sell
5,286
-128
-2% -$4.88K ﹤0.01% 3570
2025
Q3
$205K Buy
+5,414
New +$202K ﹤0.01% 3468
2024
Q4
Sell
-24,462
Closed -$816K 3599
2024
Q3
$816K Sell
24,462
-8,814
-26% -$288K ﹤0.01% 2014
2024
Q2
$1.07M Sell
33,276
-32,177
-49% -$1.01M ﹤0.01% 1721
2024
Q1
$2.04M Sell
65,453
-41,810
-39% -$1.29M 0.01% 1247
2023
Q4
$3.28M Sell
107,263
-15,266
-12% -$452K 0.01% 914
2023
Q3
$3.54M Buy
122,529
+36,093
+42% +$1.05M 0.02% 834
2023
Q2
$2.5M Buy
+86,436
New +$2.42M 0.01% 1036

Other funds holding XBAP

Cambridge Investment Research Advisors's XBAP Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Innovator US Equity Accelerated 9 Buffer ETF April (XBAP) in Q1 2026, closing a stake of 5,286 shares — an estimated $204K sold.

Cambridge Investment Research Advisors first reported a position in XBAP in Q2 2023 and held it in 8 quarters. The position peaked at $3.54M in Q3 2023. 54 funds tracked by Wall St. Rank hold XBAP as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Innovator US Equity Accelerated 9 Buffer ETF April position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,286 Innovator US Equity Accelerated 9 Buffer ETF April shares in Q1 2026, an estimated $204K.
  • Cambridge Investment Research Advisors first reported a position in Innovator US Equity Accelerated 9 Buffer ETF April in Q2 2023 and held it in 8 quarters.
  • Cambridge Investment Research Advisors's Innovator US Equity Accelerated 9 Buffer ETF April position peaked at $3.54M in Q3 2023.
  • 54 funds tracked by Wall St. Rank held Innovator US Equity Accelerated 9 Buffer ETF April as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.